Advertisement

Index by author

January 01, 2008; Volume 36,Issue 1

  1. Adjei, Araba A.

    1. Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1
      Anna M. Furimsky, Carol E. Green, Lewanne E. Hunt Sharp, Paul Catz, Araba A. Adjei, Toufan Parman, Izet M. Kapetanovic, Richard M. Weinshilboum and Lalitha V. Iyer
      Drug Metabolism and Disposition January 2008, 36 (1) 129-136; DOI: https://doi.org/10.1124/dmd.107.016725

  2. Andersson, Tommy B.

    1. HepaRG Cells as an in Vitro Model for Evaluation of Cytochrome P450 Induction in Humans
      Kajsa P. Kanebratt and Tommy B. Andersson
      Drug Metabolism and Disposition January 2008, 36 (1) 137-145; DOI: https://doi.org/10.1124/dmd.107.017418

  3. Backman, Janne T.

    1. Trimethoprim and the CYP2C8*3 Allele Have Opposite Effects on the Pharmacokinetics of Pioglitazone
      Aleksi Tornio, Mikko Niemi, Pertti J. Neuvonen and Janne T. Backman
      Drug Metabolism and Disposition January 2008, 36 (1) 73-80; DOI: https://doi.org/10.1124/dmd.107.018010

  4. Bennett, J.

    1. Investigation of Regional Mechanisms Responsible for Poor Oral Absorption in Humans of a Modified Release Preparation of the α-Adrenoreceptor Antagonist, 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): The Rational Use of ex Vivo Intestine to Predict in Vivo Absorption
      A. Collett, R. H. Stephens, M. D. Harwood, M. Humphrey, L. Dallman, J. Bennett, J. Davis, G. L. Carlson and G. Warhurst
      Drug Metabolism and Disposition January 2008, 36 (1) 87-94; DOI: https://doi.org/10.1124/dmd.107.016865

  5. Blough, David K.

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382

  6. Bonnardeaux, Alain

    1. Effects of Chronic Renal Failure on Liver Drug Transporters
      Judith Naud, Josée Michaud, Francois A. Leblond, Stéphane Lefrancois, Alain Bonnardeaux and Vincent Pichette
      Drug Metabolism and Disposition January 2008, 36 (1) 124-128; DOI: https://doi.org/10.1124/dmd.107.018192

  7. Bow, Daniel A. J.

    1. Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat Hepatocytes
      Daniel A. J. Bow, Jennifer L. Perry, David S. Miller, John B. Pritchard and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 198-202; DOI: https://doi.org/10.1124/dmd.107.018200

  8. Bridges, Arlene S.

    1. Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice
      Xianbin Tian, Maciej J. Zamek-Gliszczynski, Jun Li, Arlene S. Bridges, Ken-ichi Nezasa, Nita J. Patel, Thomas J. Raub and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 61-64; DOI: https://doi.org/10.1124/dmd.107.017319

  9. Brouwer, Kim L. R.

    1. Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat Hepatocytes
      Daniel A. J. Bow, Jennifer L. Perry, David S. Miller, John B. Pritchard and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 198-202; DOI: https://doi.org/10.1124/dmd.107.018200
    2. Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice
      Xianbin Tian, Maciej J. Zamek-Gliszczynski, Jun Li, Arlene S. Bridges, Ken-ichi Nezasa, Nita J. Patel, Thomas J. Raub and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 61-64; DOI: https://doi.org/10.1124/dmd.107.017319

  10. Carlson, G. L.

    1. Investigation of Regional Mechanisms Responsible for Poor Oral Absorption in Humans of a Modified Release Preparation of the α-Adrenoreceptor Antagonist, 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): The Rational Use of ex Vivo Intestine to Predict in Vivo Absorption
      A. Collett, R. H. Stephens, M. D. Harwood, M. Humphrey, L. Dallman, J. Bennett, J. Davis, G. L. Carlson and G. Warhurst
      Drug Metabolism and Disposition January 2008, 36 (1) 87-94; DOI: https://doi.org/10.1124/dmd.107.016865
« Previous (Pages : 1 2 3 4 5 6 ... 14) Next »
Back to top

In this issue

Advertisement